Publication | Closed Access

HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3

VaccinationVaccine TargetHuman RetrovirusImmunologyAntiviral ResponseVirologyVaccine DesignHivMedicineVaccine ResearchViral ImmunityTopical Dermavir PrimeHiv-1 Prophylactic Vaccine